116 related articles for article (PubMed ID: 1280891)
1. Comparison of immune responses to a native viral antigen and a synthetic peptide derived from it: implications for vaccine development.
Kumar A; Kaul S; Manivel V; Rao KV
Vaccine; 1992; 10(12):814-6. PubMed ID: 1280891
[TBL] [Abstract][Full Text] [Related]
2. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.
Steward MW; Sisley BM; Stanley C; Brown SE; Howard CR
Clin Exp Immunol; 1988 Jan; 71(1):19-25. PubMed ID: 3349646
[TBL] [Abstract][Full Text] [Related]
3. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
[TBL] [Abstract][Full Text] [Related]
4. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.
Leroux-Roels G; Van Hecke E; Michielsen W; Voet P; Hauser P; Pêtre J
Vaccine; 1994 Jul; 12(9):812-8. PubMed ID: 7975860
[TBL] [Abstract][Full Text] [Related]
5. Cellular recognition and HLA restriction of a midsequence HBsAg peptide in hepatitis B vaccinated individuals.
Deulofeut H; Iglesias A; Mikael N; Bing DH; Awdeh Z; Yunis J; Marcus-Bagley D; Kruskall MS; Alper CA; Yunis EJ
Mol Immunol; 1993 Jul; 30(10):941-8. PubMed ID: 8341285
[TBL] [Abstract][Full Text] [Related]
6. Human T-helper cell responses to a synthetic peptide derived from the hepatitis B surface antigen.
Mishra A; Rao KV; Durgapal H; Manivel V; Panda SK
Immunology; 1993 Jul; 79(3):362-7. PubMed ID: 7691722
[TBL] [Abstract][Full Text] [Related]
7. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.
Schirmbeck R; Böhm W; Ando K; Chisari FV; Reimann J
J Virol; 1995 Oct; 69(10):5929-34. PubMed ID: 7666497
[TBL] [Abstract][Full Text] [Related]
8. Priming biologically active antibody responses against an isolated, conformational viral epitope by DNA vaccination.
Riedl P; El-Kholy S; Reimann J; Schirmbeck R
J Immunol; 2002 Aug; 169(3):1251-60. PubMed ID: 12133946
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene, a hepatitis B vaccine containing pre-S1, pre-S2 gene products.
Pride MW; Bailey CR; Muchmore E; Thanavala Y
Vaccine; 1998 Apr; 16(6):543-50. PubMed ID: 9569463
[TBL] [Abstract][Full Text] [Related]
10. Normal HBsAg presentation and T-cell defect in the immune response of nonresponders.
Salazar M; Deulofeut H; Granja C; Deulofeut R; Yunis DE; Marcus-Bagley D; Awdeh Z; Alper CA; Yunis EJ
Immunogenetics; 1995; 41(6):366-74. PubMed ID: 7759133
[TBL] [Abstract][Full Text] [Related]
11. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity.
Milich DR; Peterson DL; Leroux-Roels GG; Lerner RA; Chisari FV
J Immunol; 1985 Jun; 134(6):4203-11. PubMed ID: 2580909
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis.
Celis E; Kung PC; Chang TW
J Immunol; 1984 Mar; 132(3):1511-6. PubMed ID: 6198394
[TBL] [Abstract][Full Text] [Related]
13. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
[TBL] [Abstract][Full Text] [Related]
14. Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen.
Schirmbeck R; Wild J; Stober D; Blum HE; Chisari FV; Geissler M; Reimann J
J Immunol; 2000 Apr; 164(8):4235-43. PubMed ID: 10754320
[TBL] [Abstract][Full Text] [Related]
15. Mimicry of the a determinant of hepatitis B surface antigen by an antiidiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and nonresponder strains.
Pride MW; Thakur A; Thanavala Y
J Exp Med; 1993 Jan; 177(1):127-34. PubMed ID: 7678109
[TBL] [Abstract][Full Text] [Related]
16. Identification of an epitope for T-cells correlated with antibody response to hepatitis B surface antigen in vaccinated humans.
Min WP; Kamikawaji N; Mineta M; Tana T; Kashiwagi S; Sasazuki T
Hum Immunol; 1996 Apr; 46(2):93-9. PubMed ID: 8727207
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
18. 48-mer synthetic peptide analogue of the hepatitis B virus "a" determinant induces an anti-HBs antibody response after a single injection.
Moynihan JS; D'Mello FI; Howard CR
J Med Virol; 2000 Oct; 62(2):159-66. PubMed ID: 11002244
[TBL] [Abstract][Full Text] [Related]
19. The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
Kruskall MS; Alper CA; Awdeh Z; Yunis EJ; Marcus-Bagley D
J Exp Med; 1992 Feb; 175(2):495-502. PubMed ID: 1531063
[TBL] [Abstract][Full Text] [Related]
20. T-cell and antibody response characterisation of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing hepatitis B vaccine; demonstration of superior anti-SHBs antibody induction in responder mice.
Jones CD; Page M; Bacon A; Cahill E; Bentley M; Chatfield SN
Vaccine; 1999 Jun; 17(20-21):2528-37. PubMed ID: 10418899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
